Investments in life sciences can be appealing to many investors as vaccines are rolled out
- On March 31, 2021
- By GrowthInvest Marketing
The past twelve months have showcased the importance of medical developments like never before. Innovation in the life sciences sector has been headline news around the globe and all aspects of the healthcare system have been under the microscope. Not only the direct response to the global pandemic, with vaccinations and treatments, but also the importance of mental health, the care home profession, screening programs and telemedicine, have had the spotlight shone on them.
Like never before, the superheroes in the medical profession have been applauded and profiled. In the UK, we have taken great pride in the development of treatments and vaccines, which have highlighted how the UK continues to be a great home for innovation across the life sciences spectrum.
GET IN TOUCH!
MAIL US
enquiries@growthinvest.comCALL US
020 7071 3945FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.
GrowthInvest is a trading name of EIS Platforms Limited. EIS Platforms Limited (FRN: 694945) is an appointed representative of Sapphire Capital Partners LLP (FRN:565716) which is authorised and regulated by the Financial Conduct Authority in the UK.
All rights reserved 2024 @ growthinvest